Vice President Global Life Sciences - CQfluency
The Netherlands
Joined March 2009
- Tweets2.2K
- Following456
- Followers547
- Likes41
Groenteman is te irritant voor woorden. Hij snapt er helemaal niets van en hinnikt inderdaad overal doorheen!
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Looking forward to attending this year's Annual @ISOQOL conference in Cologne for the next three days, October 13-16. Great agenda and roster of speakers. Looking also forward to learning a lot and meeting new people
Guilty until proven innocent. Thank you Sweden…❤️
As a result of no participation from the Netherlands in the Eurovision Song Contest Grand Final the following will take effect:
All contestants keep their number in the official Running Order. There will be NO song in position number 5.
The jury results, received after Dress Rehearsal 2 on Friday 10 May have been recalculated so that the Netherlands will not receive any points. This is why all jury members have to rank all songs from 1 to 26.
For example if the Netherlands was ranked 9th by a national jury in a country the 10th ranked song is now ranked 9th and will receive 2 points and the former 11th ranked song is now 10th and gets 1 point.
No points will be awarded to the Netherlands from the viewing public.
Viewers in the Netherlands are still allowed to vote in the Grand Final and the Netherlands Jury result in still valid.
The EBU will inform all telecommunications partners that the Netherlands is no longer participating, and we will endeavor to block the lines for Song 5. We ask that no one attempts to vote for Song 5. Should anyone try to vote for song 5 their votes will not count but there is a possibly viewers may be charged.
The Netherlands will not appear on the scoreboard.
Visit this link for more information: eurovision.tv/vote
The new EU pharmaceutical legislation will be guided by 3 A's, i.e. Affordability, Accessability and Availabilitym and 3 S's: Sustainability, Solidarity and Social contract #HEOR #CQfluency #ISPOREurope
For the 2020 EU legislation revision for pharma, 4 pillars were identified: 1. make medicines affordable to all; 2. foster sustainability and competitive innovation; 3. strong EU voice globally and 4. increased preparedness for crises. #ISPOREurope #healthcare #HEOR
The EU pharmaceutical legislation originates from 1965, and was updated in 2004. In 2020 in light of COVID-19 and as part of the EU pharma strategy, the Commission planned another revision of the general EU legislation of medicines for human use. #ISPOREurope #healthcare #HEOR
#ISPOREurope President of @ISPORorg sharing the presidential vision on thee 2024 strategy. Value driven innovation, increase passion in the different disciplines, training, education and more #healthcare #HEOR
Looking forward to yet another interesting day at 2023 #ISPOREurope with the keynote on the new pharma regulation starting soon.
Last session of day I at @ISPORorg with representatives from @BayerPharma @GatesMRI and University of Birmingham. @CQfluency
The caveats of SLR (Systematic Literature Review): lack of transparency used by AI for decision-making (black-box), AI dependency on biasness in the training set and ethical implications. @ISPORorg @CQfluency
Did you know that according to @Parexel approximately 70% of adults in the USA have concerns about the increase use of AI in healthcare and that younger patients are more willing to engage? @ISPORorg @CQfluency
Very excited to hear what lies ahead, @ISPORorg !
ISPOR is developing a new strategic plan with the future in mind and that will be launch in May at ISPOR 2024 in Atlanta. #ISPOREurope #HEOR #healthcare
Talking about Diversity in patient recruitment during @ISPORorg. According to the US National Health Council, the Asian population in the US doubled from 11.9 mio in 2020 to 22.4 mio in 2022 and is expected to reach 46 mio by 2060. @CQfluency @diversity
The afternoon of the first day of @ISPORorg ongoing. HEOR at the Nexus of Policy and Science. Great enlightning introductory and advanced session on a number of themes. Happy attending part II!
Interesting consideration posed at #ISPOREurope on Patient and public involvement and engagement (PPIE) by @sheffielduni : are we aiming for the impossible and if we don't, are we going to be exposed to criticism? @CQfluency
For meaningful patient engagement we need to value all voices. Besides relationship building, communication and education, foster trust, self-awareness and acceptance.@CQfluency @ISPORorg #patientcentricity @diversityandinclusion
Interesting to see what @ISPORorg attendees see as the biggest challenges when it comes to "patient engagement" @CQfluency #patientengagement #Diversity and #diversityandinclusion
Interesting data from a @McKinsey report stating that the anticipated impact of generative AI across the pharma industry will be $60-110 billion, which is 3%-5% of total industry revenue! @ISPORorg #GenerativeAI @CQfluency